OTCMKTS:EAPIF Euroapi (EAPIF) Stock Price, News & Analysis C$0.89 0.00 (0.00%) As of 10/30/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChart About Euroapi Stock (OTCMKTS:EAPIF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Euroapi alerts:Sign Up Key Stats Today's RangeC$0.89▼C$0.8950-Day RangeC$0.84▼C$1.1752-Week RangeC$0.84▼C$3.47Volume14 shsAverage Volume1,659 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview EUROAPI is a France-based pharmaceutical company that develops, manufactures and markets active pharmaceutical ingredients (APIs), the substances responsible for the therapeutic effects of medicines. The company supplies APIs for use in a range of prescription and over-the-counter medicines, serving pharmaceutical companies and other healthcare customers. Its portfolio includes chemical and biological APIs, as well as specialized products such as peptides and complex molecules. EUROAPI also provides contract development and manufacturing services, supporting customers from process development and scale-up through commercial production and regulatory supply. EUROAPI was established in 2022 through the separation and listing of Sanofi’s API business. The company operates an international manufacturing and research network with sites in France, Germany, Italy, Hungary and the United Kingdom, serving customers in European and other global pharmaceutical markets.AI Generated. May Contain Errors. Read More Receive EAPIF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Euroapi and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EAPIF Stock News HeadlinesMedisca and EUROAPI Form Strategic Partnership to Strengthen API Access for Pharmaceutical CompoundingOctober 7, 2026 | businesswire.comEuroapi S.A. (EAPIF) Q2 2026 Earnings Call TranscriptJuly 30, 2026 | seekingalpha.comGovernment Document Reveals Plan To Control Your Money (it will disturb you)A Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's visibility into consumer bank transactions. A pilot program is reportedly already underway, with wider rollout at major banks possibly beginning this summer. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what the document says and what steps account holders might consider.November 2 at 1:00 AM | Weiss Ratings (Ad)EUROAPI statement regarding the Brindisi siteMay 13, 2026 | globenewswire.comEUROAPI - Availability of the 2025 Universal Registration DocumentMarch 27, 2026 | globenewswire.comEuroapi S.A. (EAPIF) Q4 2025 Earnings Call TranscriptMarch 4, 2026 | seekingalpha.comWith Med4Cure, EUROAPI accelerates pharmaceutical innovation at the service of health sovereigntyOctober 23, 2025 | globenewswire.comScience Based Targets initiative (SBTi) validates EUROAPI's near-term climate targetsSeptember 18, 2025 | globenewswire.comSee More Headlines EAPIF Stock Analysis - Frequently Asked Questions How have EAPIF shares performed this year? Euroapi's stock was trading at C$2.63 at the beginning of 2026. Since then, EAPIF stock has decreased by 66.2% and is now trading at C$0.89. How do I buy shares of Euroapi? Shares of EAPIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:EAPIF CIKN/A Webwww.euroapi.com Phone33 1 89 20 62 00FaxN/AEmployees3,133Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (OTCMKTS:EAPIF) was last updated on 10/30/2026 by MarketBeat.com Staff. From Our PartnersThe most dangerous moment in a financial crisisDr. Martin D. Weiss has publicly predicted six major American crashes since founding Weiss Ratings in 1971. ...Weiss Ratings | SponsoredI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...Behind the Markets | Sponsored80 Days Until the Pentagon Restricts Chinese Rare EarthsChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredElon Musk about to bankrupt Amazon, Microsoft & Google?Jeff Brown, the former tech executive who called the rise of Bitcoin, Tesla, and Nvidia years early, is tracki...Brownstone Research | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredDoes your nest egg have an expiration date?A $250,000 nest egg growing at 5% a year and paying out $2,500 a month runs dry in just over a decade. Start w...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Euroapi S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Euroapi With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.